Clinical trial

Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

NCT06749041

Study summary

ClinicalTrials.gov

Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record above.

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2024-12-23

PhaseN/A

Conditions

Cardiovascular Side Effects of Clozapineunresolved

Neutropenia Due to Clozapineunresolved

General Side Effects of Clozapineunresolved

Constipation Due to Clozapineunresolved

Symptoms of Schizophreniaunresolved

Optimal Blood Sampling Time for Clozapine in Patients Who Receive Clozapine Once and Twice Dailyunresolved

Clozapine and Norclozapine Plasma Level Concentrationsunresolved

Interventions

Sponsors & collaborators

GGZ Noord-Holland-Noordlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06749041 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.